Abstract
CMV is a ubiquitous virus. In India, there is high seroendemicity with almost 99% adults showing IgG antibodies. Infection or re-activation becomes important in immunocompromised host (Transplant recipients, Cancer therapy patients and patients with HIV/AIDS). Neonates form a distinctive high risk population for congenital CMV infection and suffer disastrous sequlae of the same. Neonatal infections may be congenital in nature or may be acquired after birth during first month of life via infected breast milk or due to exposure to high risk blood products. The risk for transmission of the virus to the fetus is higher in primary infected mothers than in mothers with reactivated disease. Primary CMV infections are reported in 1–4% of seronegative women during pregnancy and the risk for viral transmission to fetus is 30–40%. Reactivation of a CMV infection during pregnancy is reported in 10–30% of seropositive women and the risk of transmitting the virus is about 1–3%. The adverse outcome of congenital neonatal CMV infection includes-microcephaly (70%), intellectual impairment (60%), sensineural hearing loss (35%), choriorenitis (22%), hepatosplenomegaly (70%), jaundice (68%), thrombocytopenia (65%), low birth weight (65%), pneumonitis (2–5%) and congenital heart disease (<5%). About 5–10% of congenitally infected asymptomatic infants will have neurological problems later in life the most common of which is unilateral or bilateral sensory neural hearing loss.
All immunocompromised hosts, including pre-term neonates, mount weak antibody responses (IgM), making serological detection of CMV infection in them, fallacious. Thus, it is imperative to use antigen detection methods such as quantitative PCR or PP65 Antigenaemia assays to detect CMV infection in immunocompromised host. Sakhuja et al and Minz et al have demonstrated that PP65 Antigenaemia assay is very good for diagnosing CMV disease in renal transplant recipients. The present review tends to highlight the role of newer diagnostic modalities in early CMV infection detection in neonatal population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mukundun P, Jadhav M, Jacob John T. Prevalence of cytomegalovirus antibody in young children in vellore. Indian J of Med Res 1997;65:589–592.
Gandhoke I, Aggarwal R, Lal S, Khare S. Congenital CMV infection in symptomatic infants in Delhi and surrounding areas. Indian J Pediatr 2006;73:1095–1097.
Stagno S and Britt B, Cytomegalovirus. In: Remington J S, Klein J O, Wilson C B, Baker C J, eds. Infectious diseases of the fetus and newborn infant 6th ed, Elsevier Saunders, Philadelphia, 2006;740–781.
Gaytant M A, Steegers E A, Semmekrot B A, Merkus H M and Galama J M, Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002;57:245–256.
Ahlfors K, Ivarsson S A, Johnsson T and Svanberg L. Primary and secondary maternal cytomegalovirus infections and their relation to congenital infection. Analysis of maternal sera. Acta Paediatr Scand 1982;71:109–113.
Stagno S, Pass R F and Dworsky M E. Congenital cytomegalovirus infection, the relative importance of primary and recurrent maternal infection, N Engl J Med 1982;306:945–949.
Boppana S B, Fowler K B, Britt W J, Stagno S, Pass R F. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus, Pediatrics 1999;104:55–60.
Ahlfors K, Ivarsson S A and Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature Scand J Infect Dis 1999;31:443–457.
Jones C A, Congenital cytomegalovirus infection. Curr Prob Pediatr Adolesc Health Care 2003;33:65–100.
S.B. Boppana, R.F. Pass, W.J. Britt, S. Stagno and C.A. Alford, Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992;11:93–99.
Noyola D E, Demmler G J, Nelson C T, Griesser C, Williamson W D, Atkins J T et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection J Pediatr 2001;138:325–331.
Gunilla M, Mona-Lisa Engman; Congenital cytomegalovirus infections. Seminars in Fetal & Neonatal Medicine 2007;12:154–159.
Sakhuja V, Jha V, Joshi K et al, Cytomegalovirus disease among renal transplant recipients in India. Nephrology 2002;7, 125–129.
Minz RW, Minz M, Kashyap R et al. Therapeutic implication of quantitative pp65 antigen assay in living renal transplant in a high seroendemic population. Transplant Proc 2004;36:2120–2121.
Gleaves CA, Hursh DA, Meyers JD. Detection of human CMV in clinical specimens in centrifugation culture with a non-human cell line. J Clin Microbiology 1992;30:1045–1048.
Buller RS, Bailey TC, Eltingui NA et al. Use of a modified shell vial technique to quantitate CMV viraemia in a population of solid organ transplant recipients. J Clin Microbiology 1992;30:2620–2624.
Mayo DR, Brennan T, Sirpenski SP, Seymour C. CMV antibody detection by three commercially available assays and complement fixation. Diag Microbiology Infectious Diseases 1985;3:455–459.
McHugh TM, Casavant CH, Wilber JC and Slites DP. Comparison of six methods for detection of antibody to CMV. J Clin Microbiology 1985;22:1044–1049.
Gerna G, Zipeto D, Parea M et al. Early virus isolation, early structural antigen detection and DNA amplification by the PCR in polymorphonuclear leucocytes from AIDS patients with human CMV viraemia. Molecular Cell Probes 1991;5:365–74.
Boeckh M, Woogerd PM, Stevens Ayers T, Ray CG, Bowden RA. Factors influencing detection of quantitative CMV antigenemia. J Clin Microbiology 1994;32:832–834.
A Kulkarni, D Westmoreland, JD Fox. Molecular based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipient. Clinical Microbiology and Infection 2001;7:179–184.
Schirm Jurgen et al. Sensitivity and specificity of various assays used for CMV detection. Digene laboratory data online, 2001.
Marinus J Block, Valere J Goossens, Sabina JV Vanherle et al. Diagnostic value of monitoring human CMV late pp67 RNA expression in renal allograft recipients by NASBA. J Clin Microbiology. 1998;36:1341–1346.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prateek, B., Narang, A. & Minz, R.W. Neonatal cytomegalovirus infection: Diagnostic modalities available for early disease detection. Indian J Pediatr 77, 77–79 (2010). https://doi.org/10.1007/s12098-009-0255-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-009-0255-2